Results 241 to 250 of about 124,112 (267)
Orphan Enzymes in the Mammalian L-Fucose Degradation Pathway. [PDF]
Witecka A +6 more
europepmc +1 more source
Personalized drug discovery from rare diseases to cancer. [PDF]
Katanaev VL.
europepmc +1 more source
Navigating the uncharted: AI-driven advances in protein structure, dynamics, interactions and ligand interactions for understudied families. [PDF]
Singh S, Singh R, Sharma S.
europepmc +1 more source
The neonatal continuous glucose monitoring paradox: why at-risk infants still lack access to a transformative technology-A call for needs-led innovation. [PDF]
Duncan A, Burgess H, Beardsall K.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Orphan Crops and their Wild Relatives in the Genomic Era
Molecular Plant, 2021Chuyu Ye, Longjiang Fan
exaly
Disentangling the Cost of Orphan Drugs Marketed in the United States
Healthcare, 2023Enrique Seoane-Vazquez +2 more
exaly
Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs
Journal of General Internal Medicine, 2020James D Chambers +2 more
exaly

